SLC26A3 and neoplasm: Both SLC5A8 and SLC26A3, were elevated in cecum (Fig. 5/Supplementary File S7, GEO Accession no. GSE106375) in response to HFD + inul and HFD + inul PB, and are tumour suppressors30,31 with SLC5A8 also linked to butyrate and propionate uptake32.